A method for coating fucoidan onto bare metal stent and in vivo evaluation

Progress in Organic Coatings

Volumn 78, Issue , 2015, Pages 348-356

  Kim, Jong Min ^a,b   Bae, In Ho ^a,b   Lim, Kyung Seob ^a   Park, Jun Kyu ^c   Park, Dae Sung ^a,b   Lee, So Youn ^a,b   Jang, Eun Jae ^a,b   Ji, Mi Seon ^a   Sim, Doo Sun ^a   Hong, Young Joon ^a   Ahn, Youngkeun ^a   Park, Jong Chun ^a   Cho, Jeong Gwan ^a   Kang, Jung Chaee ^a   Kim, In Su ^a   Jeong, Myung Ho ^a,b  

^a Chonnam National University Medical School   (South Korea)

^b Korea Cardiovascular Stent Research Institute   (South Korea)

^c Sunchon National University   (South Korea)

Author keywords

Coating method; Coronary stent; Fucoidan; In vivo evaluation; Polysaccharide

Indexed keywords

CELL PROLIFERATION; DISEASES; POLYSACCHARIDES; STENTS;

COATING METHODS; CORONARY STENTS; FUCOIDANS; IN-STENT RESTENOSIS; IN-VIVO; INHIBITORY EFFECT; MULTI-LAYER-COATING; SMOOTH MUSCLE CELL PROLIFERATION;

COATINGS;

EID: 85027927916     PISSN: 03009440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.porgcoat.2014.07.013     Document Type: Article

References (47)

1. X. Wu, G. Wang, C. Tang, D. Zhang, Z. Li, and D. Du Mesenchymal stem cell seeding promotes reendothelialization of the endovascular stent J. Biomed. Mater. Res. A 98 2011 442 449
2. G. Mani, N. Torres, and S. Oh Paclitaxel delivery from cobalt-chromium alloy surfaces using self-assembled monolayers Biointerphases 6 2011 33 42
3. C. Kaufmann, G. Mani, D. Marton, D. Johnson, and C.M. Agrawal Long-term stability of self-assembled monolayers on electropolished L605 cobalt chromium alloy for stent applications J. Biomed. Mater. Res. B: Appl. Biomater. 98B 2011 280 289
4. M. Early, and D.J. Kelly The consequences of the mechanical environment of peripheral arteries for nitinol stenting Med. Biol. Eng. Comput. 49 2011 1279 1288
5. J.J. Popma, R.M. Califf, and E.J. Topol Clinical trials of restenosis after coronary angioplasty Circulation 84 1991 1426 1436
6. A.W. Clowes, and M.M. Clowes Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin Lab Invest. 52 1985 611 616
7. S. Baek, and K.L. March Gene therapy for restenosis: getting nearer the heart of the matter Circ. Res. 82 1998 295 305
8. R.M. Califf, D.F. Fortin, D.J. Frid, W.R. Harlan 3rd, E.M. Ohman, and J.R. Bengtson Restenosis after coronary angioplasty: an overview J. Am. Coll. Cardiol. 17 1991 2B 13B
9. J.W. Moses, M.B. Leon, J.J. Popma, P.J. Fitzgerald, D.R. Holmes, and C. O'Shaughnessy Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N. Engl. J. Med. 349 2003 1315 1323
10. A. Dibra, A. Kastrati, F. Alfonso, M. Seyfarth, M.J. Perez-Vizcayno, and J. Mehilli Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials J. Am. Coll. Cardiol. 49 2007 616 623
11. N.A. Scott Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury Adv. Drug. Deliv. Rev. 58 2006 358 376
12. G.W. Stone, S.G. Ellis, A. Colombo, E. Grube, J.J. Popma, and T. Uchida Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program JACC Cardiovasc. Interv. 4 2011 530 542
13. F. Alfonso, J. Dutary, M. Paulo, and M.J. Perez-Vizcayno Paclitaxel-eluting balloons for sirolimus-eluting stent restenosis JACC Cardiovasc. Interv. 4 2011 716 author reply 716-717
14. G.W. Stone, J.W. Moses, S.G. Ellis, J. Schofer, K.D. Dawkins, and M.C. Morice Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
15. L. Raber, M. Magro, G.G. Stefanini, B. Kalesan, R.T. van Domburg, and Y. Onuma Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study Circulation 125 2012 1110 1121
16. L.O. Jensen, P. Thayssen, H.S. Hansen, E.H. Christiansen, H.H. Tilsted, and L.R. Krusell Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV) Circulation 125 2012 1246 1255
17. T. Kimura, T. Morimoto, M. Natsuaki, H. Shiomi, K. Igarashi, and K. Kadota Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET) Circulation 126 2012 1225 1236
18. E. Camenzind, W. Wijns, L. Mauri, V. Kurowski, K. Parikh, and R. Gao Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial Lancet 380 2012 1396 1405
19. E. Kedhi, K.S. Joesoef, E. McFadden, J. Wassing, C. van Mieghem, and D. Goedhart Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial Lancet 375 2010 201 209
20. G.W. Stone, A. Rizvi, W. Newman, K. Mastali, J.C. Wang, and R. Caputo Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N. Engl. J. Med. 362 2010 1663 1674
21. E. Regar, G. Sianos, and P.W. Serruys Stent development and local drug delivery Br. Med. Bull. 59 2001 227 248
22. A. Kerner, L. Gruberg, M. Kapeliovich, and E. Grenadier Late stent thrombosis after implantation of a sirolimus-eluting stent Catheter Cardiovasc. Interv. 60 2003 505 508
23. E.P. McFadden, E. Stabile, E. Regar, E. Cheneau, A.T. Ong, and T. Kinnaird Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521
24. C. Blondin, I. Bataille, and D. Letourneur Polysaccharides for vascular cell targeting Crit. Rev. Ther. Drug Carrier Syst. 17 2000 327 375
25. D. Logeart, S. Prigent-Richard, J. Jozefonvicz, and D. Letourneur Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization Eur. J. Cell Biol. 74 1997 376 384
26. H. Shibata, M. Iimuro, N. Uchiya, T. Kawamori, M. Nagaoka, and S. Ueyama Preventive effects of Cladosiphon fucoidan against Helicobacter pylori infection in Mongolian gerbils Helicobacter 8 2003 59 65
27. T. Teruya, T. Konishi, S. Uechi, H. Tamaki, and M. Tako Anti-proliferative activity of oversulfated fucoidan from commercially cultured Cladosiphon okamuranus TOKIDA in U937 cells Int. J. Biol. Macromol. 41 2007 221 226
28. J.W. Yang, S.Y. Yoon, S.J. Oh, S.K. Kim, and K.W. Kang Bifunctional effects of fucoidan on the expression of inducible nitric oxide synthase Biochem. Biophys. Res. Commun. 346 2006 345 350
29. A. Cumashi, N.A. Ushakova, M.E. Preobrazhenskaya, A. D'Incecco, A. Piccoli, and L. Totani A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds Glycobiology 17 2007 541 552
30. B. Li, F. Lu, X. Wei, and R. Zhao Fucoidan: structure and bioactivity Molecules 13 2008 1671 1695
31. I.H. Bae, I.K. Park, D.S. Park, H. Lee, and M.H. Jeong Thromboresistant and endothelialization effects of dopamine-mediated heparin coating on a stent material surface J. Mater. Sci. Mater. Med. 23 2012 1259 1269
32. 2 film deposited by plasma enhanced chemical vapour deposition as a drug-combining matrix J. Mater. Chem. 20 2010 4792 4801
33. D.M. Kim, B.S. Lee, J.H. Kang, J.C. Choi, K.D. Park, and T.I. Son Fabrication and controlled release of electrosprayed ReoPro-loaded metal surface for vascular stent Macromol. Res. 19 2011 501 506
34. D.S. Sim, J.S. Kwon, Y.S. Kim, H.C. Chung, Y.J. Hong, and H.W. Park Experience with endothelial progenitor cell capturing aptamers for coating of intracoronary stents in a porcine model TERM 6 2009 555 561
35. P. Buszman, S. Trznadel, A. Zurakowski, K. Milewski, L. Kinasz, and M. Krol Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions Kardiol. Pol. 65 2007 1041 1046 discussion 1047-1048
36. X. Ma, S. Oyamada, F. Gao, T. Wu, M.P. Robich, and H. Wu Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies J. Pharm. Biomed. Anal. 54 2011 807 811
37. J.M. Garasic, E.R. Edelman, J.C. Squire, P. Seifert, M.S. Williams, and C. Rogers Stent and artery geometry determine intimal thickening independent of arterial injury Circulation 101 2000 812 818
38. C. Rogers, and E.R. Edelman Endovascular stent design dictates experimental restenosis and thrombosis Circulation 91 1995 2995 3001
39. Y.K. Ahn, M.H. Jeong, J.W. Kim, S.H. Kim, J.H. Cho, and J.G. Cho Preventive effects of the heparin-coated stent on restenosis in the porcine model Catheter Cardiovasc. Interv. 48 1999 324 330
40. A.W. Heldman, L. Cheng, G.M. Jenkins, P.F. Heller, D.W. Kim, and M. Ware Jr. Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis Circulation 103 2001 2289 2295
41. C.L. Seidel Cellular heterogeneity of the vascular tunica media. Implications for vessel wall repair Arterioscler. Thromb. Vasc. Biol. 17 1997 1868 1871
42. M.C. Loya, K.S. Brammer, C. Choi, L.H. Chen, and S. Jin Plasma-induced nanopillars on bare metal coronary stent surface for enhanced endothelialization Acta Biomater. 6 2010 4589 4595
43. A. Dibra, A. Kastrati, J. Mehilli, J. Pache, R. von Oepen, and J. Dirschinger Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: a randomized double-blind controlled trial Catheter Cardiovasc. Interv. 65 2005 374 380
44. R. Richard, M. Schwarz, K. Chan, N. Teigen, and M. Boden Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations J. Biomed. Mater. Res. A 90 2009 522 532
45. L. Mu, and S.S. Feng Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers J. Control. Release 76 2001 239 254
46. S. Nakamura, M. Nambu, T. Ishizuka, H. Hattori, Y. Kanatani, and B. Takase Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization J. Biomed. Mater. Res. A 85 2008 619 627
47. S. Meng, Z. Liu, L. Shen, Z. Guo, L.L. Chou, and W. Zhong The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system Biomaterials 30 2009 2276 2283